Skepticism About Biotechnology Isn’t Anti-Science
By Tess Doezema,
Slate
| 04. 26. 2017
The debate over a fish shows that scientists can be too quick to dismiss the public’s concerns.
“Keep Frankenfish off my Dish!” a protester’s sign read. Another, adorned with six red hearts, suggested that “real people love real salmon.” A couple of years ago, protests against the approval and sale of genetically modified salmon targeted the Food and Drug Administration and supermarket chains across the country, attempting to halt the approval and sale of the AquAdvantage salmon—an Atlantic salmon modified with DNA from the Chinook salmon and the ocean pout. The borrowed genetic material lets the fish grow year-round and reach market size in half the time as its natural counterpart, but it’s also spurred passionate public debate.
In November 2015, the FDA approved the AquAdvantage salmon as the first genetically engineered animal for human consumption. According to the hype, the AquAdvantage salmon could help with reducing global hunger, decreasing the carbon footprint of aquaculture (the cultivation of fish and other aquatic life), and shoring up dwindling wild fish stock. The regulatory process behind the approval of the...
Related Articles
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
After almost 20 years of publicity stunts and dubious claims, we may not have 23andMe to kick around anymore. The company has filed for Chapter 11 bankruptcy protection. The stock has collapsed to about 2% of its peak value. CEO and co-founder Anne Wojcicki has quit (though she may be baaack) and the company’s future, if any, depends on its DNA database.
Note to customers of the company: Get Out. Cybersecurity expert Adrianus Warmenhoven told the Associated Press...
By ACLU Northern California
| 03.21.2025
In a long-standing lawsuit, the ACLU, on behalf of partner organizations and an individual taxpayer, is challenging the state of California for its retention of genetic samples and profiles from people arrested but never convicted of a felony.
The complaint...
By Loren Johnston, Portland Press Herald | 03.15.2025